NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
    NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
    Grant

    NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

    Apply by Sep 5, 2026

    About

    The NIH, CDC, and FDA are offering the Small Business Innovation Research (SBIR) grant to support U.S.-owned small businesses in conducting research and development aimed at commercializing innovative health technologies, with multiple application deadlines and phases to accommodate various project stages.

    Benefits

    • Access to early-stage funding
      Potential for commercialization of innovative products

    Eligibility Criteria

    • Must be a U.S.-owned small business
    • Must propose R&D for commercialization
    • Principal investigator must be primarily employed by the small business

    Participation Commitments

    • Conduct majority of research or analytical effort
    • Submit progress reports as required
    • Engage with program staff prior to application

    Target Region

    United States

    Target Sector

    Health Technology

    NIH, CDC, FDA

    Apply